Advertisement
Singapore markets closed
  • Straits Times Index

    3,441.77
    -2.41 (-0.07%)
     
  • S&P 500

    5,424.50
    -39.04 (-0.71%)
     
  • Dow

    40,564.59
    +24.66 (+0.06%)
     
  • Nasdaq

    17,130.38
    -239.82 (-1.38%)
     
  • Bitcoin USD

    66,100.66
    -2,034.91 (-2.99%)
     
  • CMC Crypto 200

    1,353.77
    -16.71 (-1.22%)
     
  • FTSE 100

    8,284.93
    -7.42 (-0.09%)
     
  • Gold

    2,432.10
    +6.60 (+0.27%)
     
  • Crude Oil

    74.81
    -1.00 (-1.32%)
     
  • 10-Yr Bond

    4.1710
    -0.0070 (-0.17%)
     
  • Nikkei

    38,525.95
    +57.32 (+0.15%)
     
  • Hang Seng

    17,002.91
    -235.43 (-1.37%)
     
  • FTSE Bursa Malaysia

    1,611.94
    -12.62 (-0.78%)
     
  • Jakarta Composite Index

    7,241.86
    -47.03 (-0.65%)
     
  • PSE Index

    6,606.36
    -42.87 (-0.64%)
     

Exploring Three Undervalued Small Caps With Insider Action In The United Kingdom

As the UK economy shows signs of resilience with positive GDP figures and a buoyant FTSE 100, investors are keenly watching market dynamics and potential opportunities. In this context, exploring undervalued small-cap stocks with recent insider activity could offer interesting prospects, especially given the broader market sentiment and economic indicators.

Top 10 Undervalued Small Caps With Insider Buying In The United Kingdom

Name

PE

PS

Discount to Fair Value

Value Rating

Ultimate Products

9.4x

0.7x

20.35%

★★★★★★

Norcros

7.9x

0.5x

43.52%

★★★★★☆

GB Group

NA

3.2x

22.45%

★★★★★☆

THG

NA

0.4x

40.66%

★★★★★☆

Bytes Technology Group

26.9x

6.1x

-6.53%

★★★★☆☆

CVS Group

20.3x

1.1x

43.37%

★★★★☆☆

M&C Saatchi

NA

0.6x

48.52%

★★★★☆☆

Robert Walters

19.6x

0.2x

40.76%

★★★☆☆☆

Trifast

NA

0.4x

-46.02%

★★★☆☆☆

Hochschild Mining

NA

1.8x

44.72%

★★★☆☆☆

Click here to see the full list of 33 stocks from our Undervalued UK Small Caps With Insider Buying screener.

Here we highlight a subset of our preferred stocks from the screener.

Assura

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Assura is a healthcare real estate investment trust (REIT) that focuses on the development, investment, and management of primary care facilities across the UK, with a market capitalization of approximately £1.70 billion.

Operations: Core generated £157.80 million in revenue, with a gross profit margin of 90.81% as of the latest reporting period. This reflects a cost of goods sold (COGS) totaling £14.50 million, alongside operating expenses amounting to £14.00 million within the same timeframe.

PE: -44.0x

Assura's recent strategic alliance with Universities Superannuation Scheme Limited, forming a £250 million joint venture to enhance NHS infrastructure, underscores its commitment to growth in healthcare property investment. This partnership, coupled with a significant reduction in net losses from £119.2 million to £28.8 million year-over-year and an anticipated earnings growth of 40.91%, signals strong future prospects. Additionally, insider confidence is evident as they recently purchased shares, aligning their interests with shareholders and betting on the company's success strategy focused on long-term value creation through direct NHS leases and inflation-linked rents.

LSE:AGR Share price vs Value as at Jul 2024
LSE:AGR Share price vs Value as at Jul 2024

Kier Group

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Kier Group is a construction and infrastructure services provider with operations spanning property development, building, and civil engineering, boasting a market capitalization of approximately £0.24 billion.

Operations: With a diverse revenue model spanning Construction and Infrastructure Services, the company generated £3.72 billion in its latest reporting period, showcasing a gross profit of £322.70 million. The gross profit margin has seen fluctuations over recent periods, registering at 8.68% as of the latest data point.

PE: 16.3x

Kier Group, a notable player in the UK's small-cap landscape, recently saw significant insider confidence with key stakeholders bolstering their positions through recent share purchases. With earnings expected to rise by 23% annually, this reflects a strong growth trajectory despite some financial results being skewed by one-off items. The company operates on high-risk external borrowing rather than customer deposits, indicating a reliance on volatile funding sources. This mix of insider buying and challenging capital structure presents Kier as an intriguing prospect for those eyeing potential in undervalued entities.

LSE:KIE Share price vs Value as at Jul 2024
LSE:KIE Share price vs Value as at Jul 2024

THG

Simply Wall St Value Rating: ★★★★★☆

Overview: THG is a diversified e-commerce company operating in beauty, nutrition, and technology sectors with a market capitalization of approximately £1.08 billion.

Operations: The company's gross profit margin has fluctuated over the years, peaking at 0.46% in 2018 and showing a decline to around 0.42% by the end of 2023. Revenue growth has been substantial, escalating from £184.31 million in 2013 to £2.05 billion by late 2023, despite net income remaining negative in recent periods due to increasing operating expenses and non-operating losses.

PE: -3.7x

Amidst investor activism, THG has been highlighted by Kelso Group as significantly undervalued compared to its market cap, advocating for a strategic shift to unlock value. Despite current unprofitability and reliance on external borrowing, insider confidence is evident as they recently purchased shares, signaling belief in the company's prospects. With anticipated revenue growth between 2% and 5% in H1 2024 and higher in H2 due to new contracts and brand expansions, THG's financial trajectory appears poised for improvement.

LSE:THG Share price vs Value as at Jul 2024
LSE:THG Share price vs Value as at Jul 2024

Seize The Opportunity

Seeking Other Investments?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include LSE:AGR LSE:KIE and LSE:THG.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com